1 - 25 of
48
results
for author:"Gibson R."
in Literature Citations
| A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson disease. Nishioka K., Kefi M., Jasinska-Myga B., Wider C., Vilarino-Guell C., Ross O.A., Heckman M.G., Middleton L.T., Ishihara-Paul L., Gibson R.A. et al. J. Neurol. Neurosurg. Psychiatr. 0:0-0(2009) · Mapped (19) |
| Plasma apelin levels in obstructive sleep apnea and the effect of continuous positive airway pressure therapy. Henley D.E., Buchanan F., Gibson R., Douthwaite J.A., Wood S.A., Woltersdorf W.W., Catterall J.R., Lightman S.L. J. Endocrinol. 203:181-188(2009) · Mapped (3) |
| Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. International MS Genetics Consortium Nat. Genet. 41:776-782(2009) · Mapped (15) |
| CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic. Abraha A., Nankya I.L., Gibson R., Demers K., Tebit D.M., Johnston E., Katzenstein D., Siddiqui A., Herrera C., Fischetti L. et al. |
| ATP13A2 variability in Parkinson disease. Vilarino-Guell C., Soto A.I., Lincoln S.J., Ben Yahmed S., Kefi M., Heckman M.G., Hulihan M.M., Chai H., Diehl N.N., Amouri R. et al. |
| Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Filippini N., Rao A., Wetten S., Gibson R.A., Borrie M., Guzman D., Kertesz A., Loy-English I., Williams J., Nichols T. et al. Neuroimage 44:724-728(2009) · Mapped (6) |
| Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Baranzini S.E., Wang J., Gibson R.A., Galwey N., Naegelin Y., Barkhof F., Radue E.W., Lindberg R.L., Uitdehaag B.M., Johnson M.R. et al. Hum. Mol. Genet. 18:767-778(2009) · Mapped (1) |
| Irinotecan-induced mucositis is associated with changes in intestinal mucins. Stringer A.M., Gibson R.J., Logan R.M., Bowen J.M., Yeoh A.S., Laurence J., Keefe D.M. Cancer Chemother. Pharmacol. 64:123-132(2009) · Mapped (1) |
| PINK1 mutations and parkinsonism. Ishihara-Paul L., Hulihan M.M., Kachergus J., Upmanyu R., Warren L., Amouri R., Elango R., Prinjha R.K., Soto A., Kefi M. et al. Neurology 71:896-902(2008) · Mapped (1) |
| LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Hulihan M.M., Ishihara-Paul L., Kachergus J., Warren L., Amouri R., Elango R., Prinjha R.K., Upmanyu R., Kefi M., Zouari M. et al. Lancet Neurol 7:591-594(2008) · Mapped (4) |
| Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Logan R.M., Stringer A.M., Bowen J.M., Gibson R.J., Sonis S.T., Keefe D.M. Cancer Biol. Ther. 7:1139-1145(2008) · Mapped (4) |
| Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB. Patel S., Hamill T.G., Connolly B., Jagoda E., Li W., Gibson R.E. Nucl. Med. Biol. 34:1009-1017(2007) · Mapped (4) |
| Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Cavalleri G.L., Weale M.E., Shianna K.V., Singh R., Lynch J.M., Grinton B., Szoeke C., Murphy K., Kinirons P., O'Rourke D. et al. Lancet Neurol 6:970-980(2007) · Mapped (21) |
| A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2. Yeoh A.S., Gibson R.J., Yeoh E.E., Bowen J.M., Stringer A.M., Giam K.A., Keefe D.M. Mol. Cancer Ther. 6:2319-2327(2007) · Mapped (10) |
| Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden. Lincz L.F., Lonergan A., Scorgie F.E., Rowlings P., Gibson R., Lawrie A., Seldon M. Pathophysiol. Haemost. Thromb. 35:435-439(2006) · Mapped (12) |
| Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells. Arboleda G., Huang T.J., Waters C., Verkhratsky A., Fernyhough P., Gibson R.M. Eur. J. Neurosci. 25:3030-3038(2007) · Mapped (5) |
| Molecular basis for trehalase inhibition revealed by the structure of trehalase in complex with potent inhibitors. Gibson R.P., Gloster T.M., Roberts S., Warren R.A., Storch de Gracia I., Garcia A., Chiara J.L., Davies G.J. Angew. Chem. Int. Ed. Engl. 46:4115-4119(2007) · Mapped (1) |
| A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease. Warren L., Gibson R., Ishihara L., Elango R., Xue Z., Akkari A., Ragone L., Pahwa R., Jankovic J., Nance M. et al. Parkinsonism Relat. Disord. 14:77-80(2008) · Mapped (4) |
| Integrin-binding RGD peptides induce rapid intracellular calcium increases and MAPK signaling in cortical neurons. Watson P.M., Humphries M.J., Relton J., Rothwell N.J., Verkhratsky A., Gibson R.M. Mol. Cell. Neurosci. 34:147-154(2007) · Mapped (2) |
| Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Ishihara L., Gibson R.A., Warren L., Amouri R., Lyons K., Wielinski C., Hunter C., Swartz J.E., Elango R., Akkari P.A. et al. Mov. Disord. 22:55-61(2007) · Mapped (4) |
| Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Logan R.M., Gibson R.J., Sonis S.T., Keefe D.M. Oral Oncol. 43:395-401(2007) · Mapped (7) |
| Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Ishihara L., Warren L., Gibson R., Amouri R., Lesage S., Durr A., Tazir M., Wszolek Z.K., Uitti R.J., Nichols W.C. et al. Arch. Neurol. 63:1250-1254(2006) · Mapped (4) |
| The DNA sequence and biological annotation of human chromosome 1. Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A. et al. Nature 441:315-321(2006) · UniProtKB (2,571) |
| DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R., Nicholson C., Searle S.M., Wilming L., Young S.K. et al. Nature 440:1045-1049(2006) · UniProtKB (913) |
| Interleukin-2 in human milk: a potential modulator of lymphocyte development in the breastfed infant. Bryan D.L., Forsyth K.D., Gibson R.A., Hawkes J.S. Cytokine 33:289-293(2006) · Mapped (12) |
